Anthropic closed a $3.5 billion Series E led by Lightspeed, valuing the company at $61.5 billion, with participation from a diversified investor base including Cisco, Salesforce, and Fidelity. Concurrent with the funding, Anthropic launched Claude 3.7 Sonnet and Claude Code products, highlighted by claimed 10X revenue growth at Replit and a new high-water mark in coding abilities, plus early life sciences examples (Novo Nordisk, enzyme discovery). Structurally, this signals continued capital availability for frontier labs at high multiples tied to product momentum and enterprise customer examples. For financial institutions, the funding round and product cadence reflect confidence in monetizable capability gains, though the revenue multiplier claims remain unaudited and customer concentration is obscured.
503 other tracked developments touching the same claims.